Stay updated on Cabozantinib for Merkel Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib for Merkel Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib for Merkel Cell Carcinoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Non-significant changes observed: The two screenshots show largely the same Study Details page with no core information added or removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:20:56.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    32 days ago
    Change Detected
    Summary
    Updated to v3.2.0 with an operational status notice; removed a specific disease resource (Cutaneous neuroendocrine carcinoma) and v3.1.0 reference.
    Difference
    4%
    Check dated 2025-10-06T06:55:13.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T03:26:10.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.0.2, replacing v3.0.1, indicating a new release. The 'Back to Top' element was removed; otherwise, there are no changes to core content, pricing, stock, or time-sensitive information.
    Difference
    0.2%
    Check dated 2025-09-14T21:39:41.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-07T18:00:34.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The web page has updated its facility name and location details while removing previous location terms and specific resources related to Merkel Cell Carcinoma. Additionally, it has introduced new topics related to skin cancer and a new version revision.
    Difference
    6%
    Check dated 2025-08-31T12:21:58.000Z thumbnail image

Stay in the know with updates to Cabozantinib for Merkel Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Merkel Cell Carcinoma Clinical Trial page.